Anna Janicka, MD, PhD
Anna Janicka has been a management board member at the Polish Society for Reproductive Medicine and Embryology as well as the Fertility and Infertility Section of the Polish Society of Gynecologists and Obstetricians and the European Society of Human Reproduction and Embryology (ESHRE) since 2014. Since 2010, she has also been directly involved in the implementation of the following programmes: “European IVF Monitoring (EIM)” for ESHRE andthe “Oocyte donation study” implemented for the ESHRE Taskforce on Cross Border Reproductive Care. She represented Poland in the ESHRE Committee of National Representative for the terms 2014-2017 and 2017-2020.
In 2002, Anna Janicka graduated as the best student in biotechnology from the University of Agriculture in Szczecin. She received the scholarship of the Minister of National Education and Sport for the academic year 2001/2002. In 2006, she defended her doctoral thesis at the Division of Genetics and Pathomorphology of the Pomeranian Medical University in Szczecin under the guidance of Prof Jan Lubiński, MD, Ph.D. and was awarded a doctoratewith distinction in medical biology. She has received multiple awards from the Health Minister for a series of publications on molecular biology and testing for inherited cancer risk. After completing her Ph.D., she started working at the Division of Genetics and Pathomorphology of the Pomeranian Medical University as well as the company ReadGene SA. In the years 2007-2010, she was also employed as an assistant at the Chemical Medicine Department of the Pomeranian Medical University. Anna Janicka has been with VitroLive since 2010 in the role of the Director for Quality Control and Development as well as the Coordinator of the Egg Donation Programme.